UNSPSC 51203302: Fingolimod

This classification denotes a biological response modifier, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 3QN8BYN5QF. European Medicines Agency schedules Fingolimod in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB31908. Fingolimod generally arises in the molecular formula C19H33NO2.

The term FINGOLIMOD is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19, No. 1, 2005, list 53.) Most nations, for tariff and trade purposes, schedule fingolimod under HS 29221980 and SITC 51461. As of Q4 2014, FINGOLIMOD remains US FDA's Preferred Term for this commodity. Fingolimod bears US NLM identifiers UMLS ID C1699926 and NCI Concept Code C74202. SMILES: CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N.

UNSPSC 51203302 Fingolimod is a Commodity code for a specific pharmaceutical product; however, the recent state and local opportunities tagged under this code do not reflect procurement of fingolimod itself. Instead, state and local governments are using this code to solicit a broader range of pharmaceuticals and medical supplies through piggyback contracts and direct purchases. The Illinois Department of Public Health leveraged a cooperative purchasing vehicle (MMCAP Infuse consortium) to award a pharmaceutical warehouse contract, while Seminole County, Florida procured naloxone and drug deactivation systems through a traditional competitive bid. These solicitations reflect state and local governments' reliance on master agreements and standing contracts to source emergency pharmaceuticals, opioid-reversal agents, and public-health supplies at volume pricing, often with quarterly or annual delivery schedules and multi-year renewal options.

Geographic activity under this code spans Florida and Illinois in the most recent opportunities on file. The Illinois Department of Public Health's $2,999,999.11 contract with Chartwell Rx LLC (awarded August 28, 2026, under piggyback solicitation 26482DPHPREPDB53392) and Seminole County's IFB 60459723LAS for naloxone and drug deactivation systems (posted June 30, 2026, due July 26, 2023) represent the primary recent signals. Both opportunities reflect state and local health agencies' procurement of pharmaceutical and emergency-response supplies on fixed-term contracts with renewal provisions. The mismatch between the code's nominal scope (fingolimod, a multiple sclerosis pharmaceutical) and the actual goods being solicited suggests this Commodity code may be miscoded in state and local systems or used as a catch-all for pharmaceutical inventory management — a signal that vendors pursuing pharmaceutical supply contracts should verify code alignment with procurement offices before bid preparation.